Thiazole-Pyridine Quaternary Ammonium Pleuromutilin for Resistant Pathogens
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing antibiotics are ineffective against drug-resistant bacteria and mycoplasmas, and there is a need for new antibacterial mechanisms with good bioavailability and low toxicity.
Innovation Solution
A pleuromutilin derivative containing a thiazole-pyridine benzyl quaternary ammonium salt side chain is synthesized through a series of chemical modifications, including reactions with p-toluenesulfonyl chloride, 2-mercapto-4-(4-pyridyl)thiazole, and benzyl bromide compounds, to enhance antibacterial and anti-mycoplasma activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing antibiotics are used, then they have been widely available and established mechanisms, but they are unable to treat infections caused by drug-resistant bacteria and mycoplasmas
Solution Approach 1:
The patent modifies the chemical structure of pleuromutilin by changing parameters at specific positions (C-1, C-3, C-4, C-6, C-7, C-8, C-11, C-14) to create derivatives with enhanced activity against drug-resistant bacteria and mycoplasmas. The modifications include substituting hydroxyl groups with various functional groups and adding side chains with different chemical properties to overcome resistance while maintaining the core antibacterial mechanism
Solution Approach 2:
The patent combines pleuromutilin core structure with various functional side chains including quaternary ammonium salts, thiazole rings, and aromatic groups to create composite molecular structures. These composite structures integrate the ribosomal binding capability of pleuromutilin with additional functional properties of the side chains to achieve broad-spectrum activity against resistant pathogens
2Reliability
If pleuromutilin is chemically modified to enhance antibacterial activity, then effectiveness against resistant bacteria improves, but solubility and bioavailability may be affected
Solution Approach 1:
The patent applies local quality modification by selectively modifying specific positions on the pleuromutilin molecule while leaving other regions unchanged. The C-14 position receives hydrophobic side chains to enhance membrane penetration and antibacterial activity, while the C-11 hydroxyl group is modified with polar groups to maintain solubility. This localized approach allows optimization of different properties at different molecular regions
Solution Approach 2:
The patent systematically varies chemical parameters at different positions of the pleuromutilin molecule to balance antibacterial activity and solubility. By changing the nature of substituents (hydrophobic vs. hydrophilic) at specific positions and adjusting side chain length and composition, the patent optimizes the balance between enhanced antibacterial effectiveness and maintained solubility for drug delivery
Data Source
AI summary
The present invention discloses a pleuromutilin derivative containing thiazole-pyridine benzyl quaternary ammonium salt side chain and a preparation method and use thereof and belongs to the field of medicinal chemistry. A pleuromutilin derivative with thiazole-pyridine benzyl quaternary ammonium salt side chain is successfully prepared by structural reconstruction of pleuromutilin and then structural modification with a quaternary ammonium salt compound. This compound synthesis method has the advantages of easily available raw materials, simple operation and high product yield, and is suitable for industrial production. The results of in vitro pharmacological experiments show that the pleuromutilin derivative of the present invention have good antibacterial and anti-mycoplasma activities, as well as good solubility, and these results show that the pleuromutilin derivative is of great value in the development of an anti-pathogenic microorganism drug.